Animal Health

Animal Health


Non-medicated anti-diarrhoeal

Currently in the early stages of commercialisation, Terragen’s probiotic formulation, ‘Mylo’, is targeting the significant opportunities in ruminant and mono-gastric production systems as a non-medicated anti-diarrhoeal product. Mylo is currently available in New Zealand and regulatory applications are being prepared to allow distribution in Australia and other international markets.


Terragen’s advanced stage research into anti-inflammatory products for animal industries has focused on the prevention and treatment of dairy mastitis, a disease which is estimated to cost the dairy industries of developed global economies more than $6 billion per annum.

Our products in development have the potential to substantially reduce the massive losses in animal industries caused by inflammation, minimize the need for withholding periods during treatment and contribute to lower use of antibiotics.